Skip to main content
. 2023 Mar 14;11(1):50. doi: 10.3390/diseases11010050

Figure 2.

Figure 2

Bar graph representing the effect of GLP-1RA treatment on BMI and HbA1c in diabetic patients. Two groups of diabetic patients received GLP-1RA treatment for six months. Alongside their regular diabetes management medication, the first group of patients was on an antihyperlipidemic drug (Statin), and the 2nd group was not. (A) The effect on BMI significantly decreased only in the group taking statins. (B) GLP-1RA treatment has an effect of HbA1c on both groups, the effect more significant in the statin group. Data presented as mean ± SEM, *** p-value ≤ 0.001, * p-value ≤ 0.05., ns: non-significant.